Healthcare Company Announces 400-Bed Hospital in Varanasi; Plans Rs 550 Crore Expansion

On Friday, March 27, 2026, markets closed on a negative note, with the Nifty 50 declining 2.09 per cent to Rs 22,819.60. Amid the broader market weakness, Global Health (Medanta) share price closed 2.57 per cent lower at Rs 985.30, after the company announced plans to set up a 400-bed multi-speciality hospital in Varanasi, Uttar Pradesh, as part of its expansion strategy.

Medanta to set up 400-bed hospital in Varanasi with investment of up to Rs 550 crore; also plans medical college expansion

Global Health Ltd (Medanta), in its board meeting held on March 25, 2026, approved multiple strategic initiatives aimed at expanding its healthcare and education footprint. The company has approved entering into a build-to-suit and lease agreement with Shripal Hospitality LLP and others to develop a 400+ bed multi-speciality hospital in Varanasi, Uttar Pradesh. Under this arrangement, the partner will develop the hospital infrastructure, while Medanta will invest in interiors, medical equipment, and related facilities, with a total estimated investment of up to Rs 550 crore. The project is expected to be completed within approximately four years, subject to approvals, and is aimed at strengthening the company’s presence in Uttar Pradesh and catering to the growing demand for advanced healthcare in the region.

Further, the company has also revised its approach towards setting up a medical college. Earlier planned through a subsidiary, the board has now approved that the application will be made directly through the company, following regulatory changes that allow companies to establish medical colleges. The proposed medical college project has an estimated cost of Rs 322 crore and is aimed at building a pipeline of skilled medical professionals while enhancing healthcare infrastructure. Overall, these developments reflect Medanta’s focus on expansion, capacity addition, and long-term growth in both healthcare delivery and medical education.

About Global Health

Global Health Ltd, operating under the Medanta brand, is one of India’s leading private multi-speciality tertiary healthcare providers. Founded by renowned cardiac surgeon Dr Naresh Trehan, the company offers advanced medical care across key specialities, including cardiology, oncology, neurosciences, orthopaedics, and organ transplants.

Medanta operates a network of hospitals across cities such as Gurugram, Indore, Ranchi, Lucknow, Patna, and Noida, with a total installed capacity of around 3,500+ beds. The company focuses on delivering high-quality, technology-driven healthcare services and continues to expand its presence to meet the growing demand for advanced medical infrastructure in India.

Global Health Ltd (Medanta) has a market capitalisation of Rs 26,458 crore. The company has reported a strong profit growth with a CAGR of 70.2 per cent over the past five years. However, despite this earnings growth, the stock has declined 19.17 per cent over the same period, underperforming the hospital industry, which delivered a return of 1.2 per cent.

Share your thoughts in the comments below.
Disclaimer: The article is for informational purposes only and not investment advice.